EFFICACY AND SAFETY OF SILDENAFIL ABOVE 60 MG DAILY IN PULMONARY ARTERIAL HYPERTENSION TREATMENT - A SYSTEMATIC LITERATURE REVIEW

被引：1
|
作者：
Cukier, F. N. [1 ]
Fernandes, R. A. [1 ]
Takemoto, M. L. S. [1 ]
Takemoto, M. M. S. [1 ]
Fujii, R. K. [2 ]
Mould, J. F. [3 ]
机构：
[1] ANOVA Knowledge Translat, Rio De Janeiro, Brazil
[2] Pfizer Pharmaceut Inc, Sao Paulo, Brazil
[3] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1394
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A488 / A488
页数：1
相关论文
共 50 条
  • [31] Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH)
    Rashid, Jahidur
    Patel, Brijeshkumar
    Nozik-Grayck, Eva
    McMurtry, Ivan F.
    Stenmark, Kurt R.
    Ahsan, Fakhrul
    [J]. JOURNAL OF CONTROLLED RELEASE, 2017, 250 : 96 - 106
  • [32] Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review
    Bruni, Cosimo
    De Luca, Giacomo
    Lazzaroni, Maria Grazia
    Zanatta, Elisabetta
    Lepri, Gemma
    Airo, Paolo
    Dagna, Lorenzo
    Doria, Andrea
    Matucci-Cerinic, Marco
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 78 : 17 - 25
  • [33] RIOCIGUAT IN THE PHARMACOLOGICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION: A SYSTEMATIC REVIEW
    Faria, G. G.
    Mosegui, G. B.
    Vianna, C. M.
    Tavares, C., V
    Cordeiro, B. C.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A200 - A200
  • [34] Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension
    Monaco, Thomas J.
    Davila, Carlos D.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1675 - 1681
  • [35] Clinical pharmacology, efficacy, and safety of selexipag for the treatment of pulmonary arterial hypertension
    Bruderer, Shirin
    Hurst, Noemie
    Remenova, Tatiana
    Dingemanse, Jasper
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 743 - 751
  • [36] The Efficacy and Safety of Sildenafil in Patients With Pulmonary Arterial Hypertension Associated With the Different Types of Congenital Heart Disease
    Zeng, Wei-Jie
    Lu, Xian-Ling
    Xiong, Chang-Ming
    Shan, Guang-Liang
    Liu, Zhi-Hong
    Ni, Xin-Hai
    Gu, Qing
    Zhao, Zhi-Hui
    Li, Jian-Jun
    He, Jian-Guo
    [J]. CLINICAL CARDIOLOGY, 2011, 34 (08) : 513 - 518
  • [37] Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis
    Shi, Qianling
    Wang, Zijun
    Yang, Nan
    Ma, Yanfang
    Chen, Yaolong
    Wei, Hulai
    Yao, Hua
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (01) : 339 - +
  • [38] Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
    Verlinden, Nathan J.
    Benza, Raymond L.
    Raina, Amresh
    [J]. PULMONARY CIRCULATION, 2020, 10 (04)
  • [39] Ocular Safety Of Chronic Sildenafil Citrate Therapy For Pulmonary Arterial Hypertension
    Wirostko, B.
    Hwang, L. -J.
    Tressler, C. S.
    Laties, A. M.
    Burgess, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [40] Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
    Dodgen, Andrew L.
    Hill, Kevin D.
    [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2015, 7 : 175 - 183
12345